The European Commission is reevaluating its investigations into major U.S. tech companies, including Apple, Meta, and Google, according to a report by the Financial Times. This review coincides with appeals from the companies to the incoming Trump administration for more favorable regulatory conditions.
The EU may narrow or adjust the scope of ongoing probes under the Digital Markets Act (DMA), a regulatory framework established to curb monopolistic practices, enforce stricter content moderation, and promote consumer-friendly policies. All cases initiated since March 2024 are under review, with potential fines and decisions on hold until the process concludes.
The EU has previously imposed hefty fines on tech giants like Apple and Google for violations of consumer laws. However, the current reassessment could signal a shift in regulatory intensity. This comes as U.S. tech CEOs are reportedly contributing to President-elect Donald Trump’s inauguration fund, hinting at potential deregulation under his administration. Key areas of focus include online content moderation and artificial intelligence policies.
Trump is set to assume office on January 20, raising questions about how the regulatory landscape will evolve for global tech firms. The EU’s decision to review its probes could have far-reaching implications for both compliance strategies and market dynamics within the tech sector.


American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
FxWirePro- Major Crypto levels and bias summary
BTC Flat at $89,300 Despite $1.02B ETF Exodus — Buy the Dip Toward $107K?
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Washington Post Publisher Will Lewis Steps Down After Layoffs
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



